Cargando…
Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review
Tumor-associated macrophage (TAM) phagocytic activity is emerging as a new mechanism to harness for cancer treatment. Currently, many approaches are investigated at the preclinical level and some modalities have now reached clinical trials, including the targeting of the phagocytosis inhibitor CD47....
Autores principales: | Lecoultre, Marc, Dutoit, Valérie, Walker, Paul R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747550/ https://www.ncbi.nlm.nih.gov/pubmed/33335026 http://dx.doi.org/10.1136/jitc-2020-001408 |
Ejemplares similares
-
Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?
por: Dutoit, Valérie, et al.
Publicado: (2016) -
Fcmr regulates mononuclear phagocyte control of anti-tumor immunity
por: Kubli, Shawn P., et al.
Publicado: (2019) -
Methods for studying antiviral functions of macrophages and mononuclear phagocytes
por: Keller, F.
Publicado: (1994) -
Granulocyte macrophage-colony stimulating factor: A key modulator of renal mononuclear phagocyte plasticity
por: Mylonas, Katie J., et al.
Publicado: (2019) -
Assessment of phagocytic activity in live macrophages-tumor cells co-cultures by Confocal and Nomarski Microscopy
por: Martinez-Marin, Dalia, et al.
Publicado: (2017)